In animal models of breast, colon, and prostate cancers, inhibition of DNMT led to MHC-I upregulation, T-cell chemotaxis, and tumor infiltration of CD8+ T cells, thus enhancing the anti-tumor effects of anti-PD-1 antibodies [141]. The gene discussed is DNMT1; the disease is neoplasm.